Arnold & Porter Kaye Scholer advised Pharmacosmos, while Ropes & Gray and Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C. represented G1 Therapeutics on the deal....
Pharmacosmos Group’s Acquisition of G1 Therapeutics
TowerBrook and CD&R’s $8.9 Billion Acquisition R1 RCM
Kirkland & Ellis is advising R1 RCM, Skadden is advising a special committee of the R1 RCM Inc. in the transaction, while Wachtell, Lipton, Rosen &...
Merck’s Acquisition of Eyebiotech
Skadden advised Eyebiotech Limited, while Gibson, Dunn & Crutcher advised Merck the deal. Merck, known as MSD outside of the United States and Canada, and Eyebiotech...
Vertex Pharmaceuticals’ Acquisition of Alpine Immune Sciences
Skadden advised Vertex Pharmaceuticals Incorporated, while Fenwick & West advised Alpine in the transaction. Vertex Pharmaceuticals Incorporated and Alpine Immune Sciences, Inc. have entered into a definitive...
Novartis’ Acquisition of MorphoSys
Skadden advised MorphoSys AG in the deal. MorphoSys AG has entered into a Business Combination Agreement with Novartis data42 AG and Novartis AG (hereinafter collectively referred...
Aventis’ Acquisition of INBRX-101
Paul, Weiss, Rifkind, Wharton and Garrison LLP is serving as legal counsel to Inhibrx, and Weil, Gotshal & Manges LLP is serving as legal counsel to...
Johnson & Johnson’s Acquisition of Ambrx Biopharma
Cravath, Swaine & Moore is serving as legal counsel to Johnson & Johnson, while Skadden is serving as legal counsel to Ambrx Biopharma on the transaction....
AbbVie’s Acquisition of Cerevel Therapeutics
Kirkland & Ellis advised AbbVie, Latham & Watkins advised Cerevel Therapeutics, Skadden advised Centerview partners LLC, as financial advisor to Cerevel Therapeutics in the transaction. AbbVie...
Mirati Therapeutics’ Merger With Bristol Myers Squibb
Kirkland & Ellis LLP advised Bristol Myers Squibb, while Skadden, Arps, Slate, Meagher & Flom LLP advised Mirat on the deal. Bristol Myers Squibb (NYSE: BMY)...
Eli Lilly’s $1.4 Billion Acquisition of POINT Biopharma
Kirkland & Ellis LLP is acting as legal counsel to Lilly, while Skadden, Arps, Slate, Meagher & Flom LLP is acting as legal counsel to POINT...
Intercept Pharmaceuticals’ Merger With Alfasigma
Skadden, Arps, Slate, Meagher & Flom LLP served as legal counsel to Intercept, while Sullivan & Cromwell LLP and Chiomenti Studio Legale, as legal counsel to...
Swedish Orphan Biovitrum’s Acquisition of CTI BioPharma
Skadden and Gibson, Dunn & Crutcher acted as legal advisor on the transaction. CTI BioPharma (Nasdaq: CTIC) (“CTI”) entered into a definitive agreement under which Swedish Orphan...